This inventor holds 1 USPTO granted patent. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Pavel Vraspír: Innovator in Pharmaceutical Chemistry
Introduction
Pavel Vraspír is a notable inventor based in Rýmařov, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on dasatinib.
Latest Patents
Vraspír holds a patent for an anhydrous form of dasatinib and the process for its preparation. This invention provides anhydrous forms of dasatinib, methods for their preparation, and pharmaceutical compositions thereof. His work is crucial in enhancing the efficacy and stability of this important pharmaceutical compound.
Career Highlights
Pavel Vraspír is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role in the company has allowed him to focus on developing innovative solutions in drug formulation and delivery.
Collaborations
Vraspír has collaborated with notable colleagues such as Ondrej Simo and Jirí Filipcík. Their combined expertise has contributed to advancements in pharmaceutical research and development.
Conclusion
Pavel Vraspír's contributions to pharmaceutical chemistry, particularly through his patent on dasatinib, highlight his role as an innovator in the industry. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile